HeartSciences Inc. HSCS
4.73
0.10
2.16%
as of 25 Sep
- Market cap
- $23.9M
- P/E
- 0.0×
Follow HSCS
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
| (1,854.69%) | (4,252.05%) | (382.44%) | (220.46%) |
+8 more TTM periods Free account |
|
| (201.67%) | (192.75%) | (128.00%) | (131.22%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (230.90%) | |
Return on Tangible Assets |
214.26% | 408.32% | (968.64%) | (396.32%) | |
Average Days of Receivables |
0.00 | — | — | 0.00 | |
Free Cash Flow per Share |
(1.94) | (2.85) | (2.34) | (2.71) | |
Free Cash Flow |
(7.12) | (7.47) | (7.39) | (7.54) | |
Capital Expenditures |
(0.32) | (0.04) | (0.05) | (0.04) | |
Piotroski F-Score |
3.00 | 2.00 | — | 6.00 | |
| Other line items | |||||
Cash ROIC |
339.07% | (394.43%) | (113.45%) | (122.25%) | |
Accounts Receivable Turnover |
0.00 | — | — | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.01 | 0.00 | 0.02 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.01 | |
Average Days of Payables |
143,585.38 | 64,544.17 | 0.00 | 18,101.72 | |
Days of Inventory on Hand |
56,575.00 | 132,941.11 | 0.00 | 37,486.64 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
13,025.59% | 0.00% | 0.00% | 16,097.82% | |
Selling, General and Administrative Expense of Revenue |
31,906.16% | 0.00% | 0.00% | 19,904.37% | |
Share Based Compensation of Revenue |
8,894.31% | 0.00% | 0.00% | 3,328.38% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.66 | 0.81 | 0.87 | 0.83 | |
Depreciation/Fixed assets |
18.82 | 15.96 | 13.75 | 13.55 | |
Capex/Depreciation |
(0.52) | (0.07) | (0.08) | (0.06) | |
Revenue per Share |
0.01 | 0.00 | 0.00 | 0.01 | |
Operating CF per Share |
(1.85) | (2.83) | (2.32) | (2.70) | |
Capex per Share |
(0.09) | (0.02) | (0.02) | (0.02) | |
Capex to Sales |
15.35 | 0.00 | 0.00 | 1.89 | |
Net Profit Margin |
(48,621.80%) | 0.00% | 0.00% | (39,460.26%) |
Columns are period end dates